SCHEMBL5222461

SCHEMBL5222461

Cc1c[c]c(-n2cc(-c3cc(C)c4ccccc4n3)cn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.42
KDM4E B2RXH2 7/20 0.41
MAPT P10636 6/20 0.41
ALDH1A1 P00352 6/20 0.41
GAA P10253 5/20 0.41
LMNA P02545 3/20 0.41
NPC1 O15118 1/20 0.41
HCRTR1 O43613 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MIF P14174 1/20 0.41
THRB P10828 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5215869 0.81 AHR (0.48) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5217889 0.79 MAPT (0.47) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5221390 0.79 MIF (0.47) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL14380692 0.79 MIF (0.47) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5219303 0.78 GRM4 (0.44) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5220967 0.77 AHR (0.45) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5215762 0.76 AHR (0.49) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5219139 0.74 MIF (0.48) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5220201 0.74 AHR (0.42) AHRKDM4EMAPTALDH1A1GAA
SCHEMBL5216628 0.74 AHR (0.47) AHRKDM4EMAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed